CoChat

Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells

Open access
Yoshimura, Teizo, Howard, O. M. Zack, Ito, Toshihiro, Kuwabara, Masaki, Matsukawa, Akihiro, Chen, Keqiang, Liu, Ying, Liu, Mingyong, Oppenheim, Joost J., Wang, Ji Ming · 2013 · PLoS ONE
Cited by 108

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

MCP-1/CCL2 plays an important role in the initiation and progression of cancer. Since tumor cells produce MCP-1, they are considered to be the main source of this chemokine. Here, we examined whether MCP-1 produced by non-tumor cells affects the growth and lung metastasis of 4T1 breast cancer cells by transplanting them into the mammary pad of WT or MCP-1(-/-) mice. Primary tumors at the injected site grew similarly in both mice; however, lung metastases were markedly reduced in MCP-1(-/-) mice, with significantly longer mouse survival. High levels of MCP-1 mRNA were detected in tumors growing in WT, but not MCP-1(-/-) mice. Serum MCP-1 levels were increased in tumor-bearing WT, but not MCP-1(-/-) mice. Transplantation of MCP-1(-/-) bone marrow cells into WT mice did not alter the incidence of lung metastasis, whereas transplantation of WT bone marrow cells into MCP-1(-/-) mice increased lung metastasis. The primary tumors of MCP-1(-/-) mice consistently developed necrosis earlier than those of WT mice and showed decreased infiltration by macrophages and reduced angiogenesis. Interestingly, 4T1 cells that metastasized to the lung constitutively expressed elevated levels of MCP-1, and intravenous injection of 4T1 cells producing a high level of MCP-1 resulted in increased tumor foci in the lung of WT and MCP-1(-/-) mice. Thus, stromal cell-derived MCP-1 in the primary tumors promotes lung metastasis of 4T1 cells, but tumor cell-derived MCP-1 can also contribute once tumor cells enter the circulation. A greater understanding of the source and role of this chemokine may lead to novel strategies for cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0058791

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 43

  1. A Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 · DOI · Paper page
  2. SI Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 · DOI · Paper page
  3. T Yoshimura, 1989, Purification and amino acid analysis of two human glioma cell-derived monocyte chemoattractants, J Exp Med, 169, 1449, 10.1084/jem.169.4.1449 · DOI · Paper page
  4. K Matsushima, 1989, Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line, J Exp Med, 169, 1485, 10.1084/jem.169.4.1485 · DOI · Paper page
  5. B Bottazzi, 1990, A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF), Int J Cancer, 45, 795, 10.1002/ijc.2910450436 · DOI
  6. B Bottazzi, 1992, Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma, J Immunol, 148, 1280, 10.4049/jimmunol.148.4.1280 · DOI · Paper page
  7. K Hirose, 1995, Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration, Br J Cancer, 72, 708, 10.1038/bjc.1995.398 · DOI · Paper page
  8. BJ Rollins, 1991, Suppression of tumor formation in vivo by expression of the JE gene in malignant cells, Mol Cell Biol, 11, 3125, 10.1128/MCB.11.6.3125 · DOI · Paper page
  9. S Yamashiro, 1994, Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors, Am J Pathol, 145, 913
  10. BK Popivanova, 2009, Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice, Cancer Res, 69, 7884, 10.1158/0008-5472.CAN-09-1451 · DOI · Paper page
  11. RD Loberg, 2007, Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo, Cancer Res, 67, 9417, 10.1158/0008-5472.CAN-07-1286 · DOI · Paper page
  12. Y Lu, 2007, Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption, Cancer Res, 67, 3646, 10.1158/0008-5472.CAN-06-1210 · DOI · Paper page
  13. X Li, 2009, A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone, Cancer Res, 69, 1685, 10.1158/0008-5472.CAN-08-2164 · DOI · Paper page
  14. X Lu, 2009, Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone, J Biol Chem, 284, 29087, 10.1074/jbc.M109.035899 · DOI · Paper page
  15. ZG Fridlender, 2011, CCL2 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells, Am, J Respir Cell Mol Biol, 44, 230, 10.1165/rcmb.2010-0080OC · DOI · Paper page
  16. K Garber, 2010, First results for agents targeting cancer-related inflammation, J Natl Cancer Inst, 101, 1110, 10.1093/jnci/djp266 · doi:10.1093/jnci/djp266
  17. M Sund, 2009, Tumor stroma derived biomarkers in cancer, Cancer Metastasis Rev, 28, 177, 10.1007/s10555-008-9175-2 · DOI
  18. A Albini, 2007, The tumour microenvironment as a target for chemoprevention, Nature Rev, 7, 139
  19. BS Weiseman, 2002, Stromal effects on mammary gland development and breast cancer, Science, 296, 1046, 10.1126/science.1067431 · DOI · Paper page
  20. H Saji, 2001, Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma, Cancer, 92, 1085, 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K · DOI · Paper page
  21. GH Heppner, 2000, Nontransgenic models of breast cancer, Breast Cancer Res, 2, 331, 10.1186/bcr77 · DOI · Paper page
  22. M Takahashi, 2009, Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A, J Immunol, 183, 3463, 10.4049/jimmunol.0802812 · DOI · Paper page
  23. T Yoshimura, 1993, cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1): NAP-1 is highly conserved in guinea pig, J Immunol, 151, 6225, 10.4049/jimmunol.151.11.6225 · DOI
  24. L Boring, 1997, Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice, J Clin Invest, 100, 2552, 10.1172/JCI119798 · DOI · Paper page
  25. GT Stathopoulos, 2008, A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion, J Natl Cancer Inst, 100, 1464, 10.1093/jnci/djn325 · DOI · Paper page
  26. B Davidson, 2008, The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions, Breast J, 14, 476, 10.1111/j.1524-4741.2008.00625.x · DOI
  27. A Müller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016 · DOI · Paper page
  28. RN Kaplan, 2006, Preparing the “soil”: the premetastatic niche, Cancer Res, 66, 11089, 10.1158/0008-5472.CAN-06-2407 · DOI · Paper page
  29. JM Wang, 1998, Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFkappaB activation, Int J Cancer, 75, 900, 10.1002/(SICI)1097-0215(19980316)75:6<900::AID-IJC13>3.0.CO;2-6 · DOI · Paper page
  30. Y Sawanobori, 2008, Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice, Blood, 111, 5457, 10.1182/blood-2008-01-136895 · DOI · Paper page
  31. JC Pahler, 2008, Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response, Neoplasia, 10, 329, 10.1593/neo.07871 · DOI · Paper page
  32. CL Chaffer, 2011, A perspective on cancer cell metastasis, Science, 331, 1559, 10.1126/science.1203543 · DOI · Paper page
  33. SK Bunt, 2007, Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression, Cancer Res, 67, 10019, 10.1158/0008-5472.CAN-07-2354 · DOI · Paper page
  34. T Ueno, 2000, Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer, Clin Cancer Res, 6, 3282
  35. J Wyckoff, 2004, A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors, Cancer Res, 64, 7022, 10.1158/0008-5472.CAN-04-1449 · DOI · Paper page
  36. JW Pollard, 2008, Macrophages define the invasive microenvironment in breast cancer, J Leukoc Biol, 84, 623, 10.1189/jlb.1107762 · DOI · Paper page
  37. C Sunderkötter, 1994, Macrophages and angiogenesis, J Leukoc Biol, 55, 410, 10.1002/jlb.55.3.410 · DOI · Paper page
  38. R Salcedo, 2000, Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression, Blood, 96, 34, 10.1182/blood.V96.1.34 · DOI · Paper page
  39. SM Stamatovic, 2006, CCL2 regulates angiogenesis via activation of Ets-1 transcription factor, J Immunol, 177, 2651, 10.4049/jimmunol.177.4.2651 · DOI · Paper page
  40. G Arderiu, 2011, Tissue factor regulates microvessel formation and stabilization by induction of chemokine (C-C motif) ligand 2 expression, Arterioscler Thromb Vasc Biol, 31, 2607, 10.1161/ATVBAHA.111.233536 · DOI
  41. KM Irvine, 2009, Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages, J Leukoc Biol, 85, 278, 10.1189/jlb.0808497 · DOI · Paper page
  42. C Franci, 1995, Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant receptor, J Immunol, 154, 6511, 10.4049/jimmunol.154.12.6511 · DOI
  43. T Jia, 2008, Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection, J Immunol, 180, 6846, 10.4049/jimmunol.180.10.6846 · DOI · Paper page

Cited by

See all 108

Metadata

Authors
Yoshimura, T., Howard, O. M. Z., Ito, T., Kuwabara, M., Matsukawa, A., Chen, K., Liu, Y., Liu, M., Oppenheim, J. J., & Wang, J. M.
Venue
PLoS ONE
Published
2013-03-18
Volume
8
Issue
3
Pages
e58791
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1989434167
Cited by
108
References
6
FWCI
6.17
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells. https://app.cochat.ai/papers/10.1371/journal.pone.0058791
The paper
Yoshimura, T., Howard, O. M. Z., Ito, T., Kuwabara, M., Matsukawa, A., Chen, K., Liu, Y., Liu, M., Oppenheim, J. J., & Wang, J. M. (2013). Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells. PLoS ONE. https://doi.org/10.1371/journal.pone.0058791

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.